β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 9, 2013, Pages 1100-1109

  Tissot, Frederic ^a   Lamoth, Frederic ^a   Hauser, Philippe M ^b   Orasch, Christina ^a,c   Flückiger, Ursula ^c   Siegemund, Martin ^d   Zimmerli, Stefan ^e   Calandra, Thierry ^a   Bille, Jacques ^b   Eggimann, Philippe ^a   Marchetti, Oscar ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Institute of Microbiology   (Switzerland)

^c Division of Infectious Diseases   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Biomarkers; Candida; Colonization; ICU; Surgery

Indexed keywords

1,3 BETA DEXTRO GLUCAN ANTIGEN; ANTIFUNGAL AGENT; BETA 1,3 GLUCAN; CARBOHYDRATE ANTIGEN; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; BLOOD LEVEL; BLOOD SAMPLING; CANDIDA; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM PERFORATION; FEMALE; FUNGAL COLONIZATION; FUNGEMIA; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; INTRAABDOMINAL CANDIDIASIS; INVASIVE CANDIDIASIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BETA-GLUCANS; CANDIDIASIS; COHORT STUDIES; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTESTINAL PERFORATION; INTRAABDOMINAL INFECTIONS; MALE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; PROSPECTIVE STUDIES; RECURRENCE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84887296457     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201211-2069OC     Document Type: Article

References (39)

1. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Tauber MG, Pittet D, et al. Epidemiology of candidemia in swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004;38:311-320.
2. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. Epic International Advisory Committee. JAMA 1995;274:639-644.
3. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P. Clinical significance of candida isolated from peritoneum in surgical patients. Lancet 1989;2:1437-1440.
4. Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP, Mantz J, Desmonts JM. Predictive factors of mortality due to polymicrobial peritonitis with candida isolation in peritoneal fluid in critically ill patients. Arch Surg 2002;137:1341-1346, discussion 1347.
5. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006;34:646-652.
6. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of candida in intraperitoneal infections. Surgery 1980;88:524-530.
7. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis survey. Clin Infect Dis 2001;33: 177-186.
8. Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, Balasini C, Utande-Vazquez A, Gonzalez de Molina FJ, Blasco- Navalproto MA, et al. Usefulness of the "Candida score" for discriminating between candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009;37:1624-1633.
9. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-1072.
10. Calandra T, Marchetti O. Clinical trials of antifungal prophylaxis among patients undergoing surgery. Clin Infect Dis 2004;39:S185-192.
11. Hoerauf A, Hammer S, Muller-Myhsok B, Rupprecht H. Intra-abdominal candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 1998;26:2010-2015.
12. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006;43:25-31.
13. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-758.
14. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007;26:271-276.
15. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. b-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011;52:750- 770.
16. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O; Third European Conference on Infections in Leukemia. b-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 2012;54:633-643.
17. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, et al. Plasma (1→3)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20.
18. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. Beta- D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199-205.
19. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, et al. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005;41:654-659.
20. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T, et al. 1, 3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878-885.
21. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1-.3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005;43:5957-5962.
22. Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, et al. Performance of Candida real-time polymerase chain reaction, b-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012;54:1240-1248.
23. Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-b-D-glucan assay, Candida score, and colonization index. Crit Care 2011;15:R249.
24. Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W. Invasive fungal infections and (1, 3)-beta-D-glucan serum concentrations in long-term intensive care patients. Int J Infect Dis 2009;13: 707-712.
25. Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L. Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011;49:58-61.
26. Takesue Y, Kakehashi M, Ohge H, Imamura Y, Murakami Y, Sasaki M, Morifuji M, Yokoyama Y, Kouyama M, Yokoyama T, et al. Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 2004;28:625-630.
27. Tissot F, Hauser PM, Eggimann P, Flueckiger U, Siegemund M, Orasch C, Zimmerli S, Calandra T, Bille J, Lamoth F, et al. Monitoring of 1, 3-beta-d-glucan in high-risk surgical ICU patients for early diagnosis of invasive candidiasis. Presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 12-15, 2010, Boston, MA. Poster M-1071.
28. Tissot F, Hauser PM, Eggimann P, Flueckiger U, Siegemund M, Orasch C, Zimmerli S, Calandra T, Bille J, Lamoth F, et al. Monitoring of 1, 3- beta-d-glucan in high-risk surgical ICU patients for early diagnosis of invasive candidiasis: a prospective study of the Fungal Infection Network of Switzerland (FUNGINOS). Presented at the Meeting of the French Society for Medical Mycology. November 26-27, 2010, Paris, France.
29. Tissot F, Hauser PM, Eggimann P, Flueckiger U, Siegemund M, Orasch C, Zimmerli S, Calandra T, Bille J, Lamoth F, et al. Monitoring of 1, 3- beta-D-glucan in high-risk surgical ICU patients for early diagnosis of invasive candidiasis. Presented at the Annual Meeting of the Swiss Society for Infectious Diseases. August 24-25, 2011, Interlaken, Switzerland. Poster P02.
30. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: Value of CT in establishing prognosis. Radiology 1990; 174:331-336.
31. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE; Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-189.
32. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012;18:19-37.
33. Eggimann P, Marchetti O. Is (1→3)-b-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care 2011;15:1017.
34. Mitsutake K, Miyazaki T, Tashiro T, Yamamoto Y, Kakeya H, Otsubo T, Kawamura S, Hossain MA, Noda T, Hirakata Y, et al. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J Clin Microbiol 1996;34:1918-1921.
35. Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1, 3)-b-Dglucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012;55:521-526.
36. Koo S, Baden LR, Marty FM. Post-diagnostic kinetics of the (1 → 3)- b-D-glucan assay in invasive aspergillosis, invasive candidiasis and pneumocystis jirovecii pneumonia. Clin Microbiol Infect 2012;18: E122-127.
37. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133-164.
38. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr., Calandra TF, Edwards JE Jr., Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-535.
39. Hanson KE, Pfeiffer CD, Lease ED, Balch AH, Zaas AK, Perfect JR, Alexander BD. Beta-d-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. PLoS ONE 2012;7:e42282.